MaxLinear Stock Gets RS Rating Lift

Blockhead
2024-12-17

The Relative Strength (RS) Rating for MaxLinear (MXL) stock jumped into a new percentile Monday, with a rise from 76 to 83.

X
RS Line vs. RS Rating: Which Is The Better Stock Indicator?
See All Videos
NOW PLAYING RS Line vs. RS Rating: Which Is The Better Stock Indicator?

IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the trailing 52 weeks matches up against the rest of the market.

Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating as they launch their biggest price moves.


Hone Your Stock-Picking Skills By Focusing On These Factors


Is MaxLinear Stock A Buy?

MaxLinear stock reclaimed its 200-day moving average in early December and has been rallying. While MaxLinear stock is not near a proper buying range right now, see if it manages to form and break out of a proper chart pattern.

The fabless chipmaker reported 0% earnings growth last quarter. Revenue increased -40%.

MaxLinear stock holds the No. 24 rank among its peers in the Electronics-Semiconductor Fabless industry group. Broadcom (AVGO), SiTime (SITM) and NVIDIA (NVDA) are among the top 5 highly rated stocks within the group. For more industry news, check out "Chip Stocks To Watch And Semiconductor Industry News."

YOU MAY ALSO LIKE:

Learn How To Time The Market With IBD's ETF Market Strategy

Find Today's Best Growth Stocks To Watch With IBD 50

Find The Best Long-Term Investments With IBD Long-Term Leaders

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10